Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Stenner
Azathioprine/Allopurinol Co-Therapy Is an Effective Treatment for Patients With Inflammatory Bowel Disease Who Exhibit No Response or Side-Effects to Thiopurines Without the Need for Metabolite Level Measurements
Gut
Gastroenterology
Related publications
Outcome of Concomitant Treatment With Thiopurines and Allopurinol in Patients With Inflammatory Bowel Disease: A Nationwide Danish Cohort Study
United European Gastroenterology Journal
Oncology
Gastroenterology
Utilisation of Erythrocyte 6-Thioguanine Metabolite Levels to Optimise Azathioprine Therapy in Patients With Inflammatory Bowel Disease
Gut
Gastroenterology
The Treatment of Inflammatory Bowel Disease With 6-Mercaptopurine or Azathioprine
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Acetarsol Suppositories: Effective Treatment for Refractory Proctitis in a Cohort of Patients With Inflammatory Bowel Disease
Digestive Diseases and Sciences
Physiology
Gastroenterology
Methotrexate Treatment for a Dog With an Inflammatory Bowel Disease
Journal of the Japan Veterinary Medical Association
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
New England Journal of Medicine
Medicine
Editorial: An Argument for Low-Dose Thiopurine Allopurinol Combination Use as First-Line Therapy in Inflammatory Bowel Disease
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Can We Predict the Toxicity and Response to Thiopurines in Inflammatory Bowel Diseases?
Frontiers in Medicine
Medicine
Systematic Review With Meta-Analysis: Thiopurines Decrease the Risk of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
